InspireMD, Inc. (NSPR): Company Cash Volume

Official company branding of InspireMD Corp (NSPR)

InspireMD, Inc. (NSPR) is capturing the carotid stenting niche through its unique embolic protection. The company's cash position demonstrates financial stability, with the parameter value reaching 0.02. Growth is based on the implementation of ESG environmental standards, while business security is ensured by a patent mesh, despite stringent clinical trial requirements.

Company Cash Funds: InspireMD Inc. (NSPR) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for InspireMD Inc (NSPR)

- stock quotes and analyst forecast:
Initial company analysis:InspireMD Inc. NSPR
Brand item of InspireMD

For an investor in InspireMD, Inc. (NSPR), a developer of unique stroke prevention systems, the fundamental liquidity assessment determines the company's ability to scale expansion within the interventional cardiology segment. The dynamics of the cash position reflect the balance between interest income generation and investments in the production of CGuard stent systems, where an excess of funds guarantees financial stability but may signal a slowdown in business development rates.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|Company Cash on Hand STXS|Company Cash Reserve Neuronetics, Inc. STIM|Company Cash Volume SGHT|Company Cash on Hand Orchestra BioMed OBIO|Company Cash Funds Anika Therapeutics Inc. ANIK|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)